Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 30.90
+0.70 (2.32%)
At close: Jan 30, 2026
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 48.47 million as of January 30, 2026. Its market cap has decreased by -8.31% in one year.
Market Cap
48.47M
Enterprise Value
74.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.90
Market Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 48.47M, a decrease of -93.92%. That is a compound annual growth rate of -14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 48.47M | 1.64% |
| Dec 31, 2025 | 47.68M | -12.89% |
| Dec 31, 2024 | 54.74M | -12.09% |
| Dec 31, 2023 | 62.27M | -36.78% |
| Dec 29, 2022 | 98.50M | -46.87% |
| Dec 30, 2021 | 185.39M | -41.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 434.47M |
| Geffen Residence & Renewal | 261.69M |
| Matricelf | 143.84M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 34.65M |
| Evogene | 27.76M |
| XTL Biopharmaceuticals | 25.55M |
| Purple Biotech | 20.44M |